However, current data are controversial regarding the effects of testosterone, as the signaling via the androgen receptor (AR) is considered to have protective function and the reduction of testosterone during aging is often associated with cardiovascular disease (CVD), metabolic syndrome (MetS), stroke, atherosclerosis and insulin resistance (for review see (Lopes et al. 2012). The gene discussed is AR; the disease is metabolic syndrome.